Ning J - Search Results

1

DUSP5 regulated by YTHDF1-mediated m6A modification promotes epithelial-mesenchymal transition and EGFR-TKI resistance via the TGF-β/Smad signaling pathway in lung adenocarcinoma.

Fan W, Xing Y, Yan S, Liu W, Ning J, Tian F, Wang X, Zhan Y, Luo L, Cao M, Huang J, Cai L. Fan W, et al. Among authors: ning j. Cancer Cell Int. 2024 Jun 13;24(1):208. doi: 10.1186/s12935-024-03382-6. Cancer Cell Int. 2024. PMID: 38872157 Free PMC article.

2

Down-regulated m6A reader FTO destabilizes PHF1 that triggers enhanced stemness capacity and tumor progression in lung adenocarcinoma.

Ning J, Wang F, Bu J, Zhu K, Liu W. Ning J, et al. Cell Death Discov. 2022 Aug 9;8(1):354. doi: 10.1038/s41420-022-01125-y. Cell Death Discov. 2022. PMID: 35945194 Free PMC article.

3

A novel epithelial-mesenchymal transition (EMT)-related gene signature of predictive value for the survival outcomes in lung adenocarcinoma.

Cui Y, Wang X, Zhang L, Liu W, Ning J, Gu R, Cui Y, Cai L, Xing Y. Cui Y, et al. Among authors: ning j. Front Oncol. 2022 Sep 15;12:974614. doi: 10.3389/fonc.2022.974614. eCollection 2022. Front Oncol. 2022. PMID: 36185284 Free PMC article.

4

[Expression and significance of clusterin in Anip973/NVB cell lines.].

Liu W, Cai L, Ning J, Li D. Liu W, et al. Among authors: ning j. Zhongguo Fei Ai Za Zhi. 2008 Oct 20;11(5):696-9. doi: 10.3779/j.issn.1009-3419.2008.05.013. Zhongguo Fei Ai Za Zhi. 2008. PMID: 20738915 Free article. Chinese.

5

Overexpression of Sphk2 is associated with gefitinib resistance in non-small cell lung cancer.

Liu W, Ning J, Li C, Hu J, Meng Q, Lu H, Cai L. Liu W, et al. Among authors: ning j. Tumour Biol. 2016 May;37(5):6331-6. doi: 10.1007/s13277-015-4480-1. Epub 2015 Dec 1. Tumour Biol. 2016. PMID: 26628299

6

Changes of N6-methyladenosine modulators promote breast cancer progression.

Wu L, Wu D, Ning J, Liu W, Zhang D. Wu L, et al. Among authors: ning j. BMC Cancer. 2019 Apr 5;19(1):326. doi: 10.1186/s12885-019-5538-z. BMC Cancer. 2019. PMID: 30953473 Free PMC article.

7

Navigating into the binding pockets of the HER family protein kinases: discovery of novel EGFR inhibitor as antitumor agent.

Liu W, Ning JF, Meng QW, Hu J, Zhao YB, Liu C, Cai L. Liu W, et al. Among authors: ning jf. Drug Des Devel Ther. 2015 Jul 23;9:3837-51. doi: 10.2147/DDDT.S85357. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26229444 Free PMC article.

8

Reducing N6AMT1-mediated 6mA DNA modification promotes breast tumor progression via transcriptional repressing cell cycle inhibitors.

Chen J, Zhuang Y, Wang P, Ning J, Liu W, Huang Y, Lin X, Peng L, Zhang D. Chen J, et al. Among authors: ning j. Cell Death Dis. 2022 Mar 7;13(3):216. doi: 10.1038/s41419-022-04661-8. Cell Death Dis. 2022. PMID: 35256595 Free PMC article.

9

YTHDF1 Promotes Cyclin B1 Translation through m⁶A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation.

Lou X, Ning J, Liu W, Li K, Qian B, Xu D, Wu Y, Zhang D, Cui W. Lou X, et al. Among authors: ning j. Cells. 2021 Jul 2;10(7):1669. doi: 10.3390/cells10071669. Cells. 2021. PMID: 34359836 Free PMC article.

10

Ran GTPase induces EMT and enhances invasion in non-small cell lung cancer cells through activation of PI3K-AKT pathway.

Ning J, Liu W, Zhang J, Lang Y, Xu S. Ning J, et al. Oncol Res. 2013;21(2):67-72. doi: 10.3727/096504013X13747716581417. Oncol Res. 2013. PMID: 24406042

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,965 results

Search Page

Filters